|   | 1. | I      have reviewed this Quarterly Report on Form 10-Q of SinoFresh Healthcare,      Inc.; |
|--------|----|---------------------------------------------------------------------------------------------|

|   | 2. | Based      on my knowledge, this report does not contain any untrue statement of a      material fact or omit to state a material fact necessary to make the      statements made, in light of the circumstances under which such statements      were made, not misleading with respect to the period covered by this      report; |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3. | Based      on my knowledge, the financial statements, and other financial information      included in this report, fairly present in all material respects the      financial condition, results of operations and cash flows of the issuer as      of, and for, the periods presented in this  report; |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 4. | I      am responsible for establishing and maintaining disclosure controls and      procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and      internal control over financial reporting (as defined in Exchange Act      Rules 13a-15(f) and 15(d)-15(f)) for the issuer and  have: |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | a. | Designed      such disclosure controls and procedures, or caused such disclosure      controls and procedures to be designed under my supervision, to ensure      that material information relating to the issuer, including its Condensed      subsidiaries, is made known to us by others within those entities,      particularly during the period in which this report is being      prepared; |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | b. | Designed      such internal control over financial reporting, or caused such internal      control over financial reporting to be designed under my supervision, to      provide reasonable assurance regarding the reliability of financial      reporting and the preparation of financial statements for external      purposes in accordance with generally accepted accounting      principles; |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | c. | Not      evaluated the effectiveness of the issuer’s disclosure controls and      procedures and presented in this report my conclusions about the      effectiveness of the disclosure controls and procedures, as of the end of      the period covered by this report based on such evaluation;      and |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | d. | Disclosed      in this report any change in the issuer’s internal control over financial      reporting that occurred during the issuer’s most recent fiscal quarter      that has materially affected, or is reasonably likely to materially      affect, the issuer’s internal control over financial reporting;      and |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 5. | I      have disclosed, based on the most recent evaluation of internal control      over financial reporting, to the issuer’s auditors and the audit committee      of the issuer’s board of directors: |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | a. | All      significant deficiencies and material weaknesses in the design or      operation of internal control over financial reporting which are      reasonably likely to adversely affect the issuer’s ability to record,      process, summarize and report financial information;  and |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | b. | Any      fraud, whether or not material, that involves management or other      employees who have a significant role in the issuer’s internal control      over financial reporting. |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                    | SINOFRESH      HEALTHCARE, INC. |                                                                                       |
|-------------------------|---------------------------------|--------------------------------------------------------------------------------------------|
|                    |                            |                                                                                       |   |
| June      18, 2008 | By:                             | /s/ Charles      A. Fust                                                              |   |
|                    |                            | Charles      A. Fust                                                                       |   |
|                    |                            | President      and Chief Executive Officer(Principal      Executive and Financial Officer) |   |
|                    |                            |                                                                                       |   |